Literature DB >> 24596217

MYH9 regulates p53 stability and is a tumor suppressor in SCC.

.   

Abstract

An in vivo RNAi screen identified nonmuscle myosin IIa (MYH9) as a tumor suppressor in SCC.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24596217     DOI： 10.1158/2159-8290.CD-RW2014-023

Source DB:  PubMed          Journal:  Cancer Discov        ISSN： 2159-8274            Impact factor:   39.397


  2 in total

1.  Novel Gene Expression Signature Predictive of Clinical Recurrence After Radical Prostatectomy in Early Stage Prostate Cancer Patients.

Authors:  Ahva Shahabi; Juan Pablo Lewinger; Jie Ren; Craig April; Andy E Sherrod; Joseph G Hacia; Siamak Daneshmand; Inderbir Gill; Jacek K Pinski; Jian-Bing Fan; Mariana C Stern
Journal:  Prostate       Date:  2016-06-08       Impact factor: 4.012

2.  ENKUR expression induced by chemically synthesized cinobufotalin suppresses malignant activities of hepatocellular carcinoma by modulating β-catenin/c-Jun/MYH9/USP7/c-Myc axis.

Authors:  Rentao Hou; Yonghao Li; Xiaojun Luo; Wan Zhang; Huiling Yang; Yewei Zhang; Jiahao Liu; Shaohua Liu; Siyuan Han; Chen Liu; Yun Huang; Zhen Liu; Aimin Li; Weiyi Fang
Journal:  Int J Biol Sci       Date:  2022-03-21       Impact factor: 6.580
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.